arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

Trulieve Cannabis Corp.

TRLV
$12.52 ▲ +0.05 (+0.44%) at close
Materials ·Medicinal Chemicals & Botanical Products ·USMedicinal Chemicals & Botanical Products
27 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
47
Health
Weak
Bearish
auto_awesome

Analytical Summary

Trulieve Cannabis Corp. faces fundamental challenges with weakness in Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $2.4B
Dividend Yield
Revenue Growth -10.3%
Op. Margin -136.7%
ROIC -200.1%
FCF / Share $0.28
Trailing P/E
Price / Book
FCF Yield 2.2%
Debt / Equity
info Valuation on last close. End-of-day price, Sep 23, 2026.

27-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$270.95M
↓ -10.3%
Net Income Profit after all expenses
$-406.06M
↓ -2420.4%
Operating Margin Operating profit as % of sales
-136.7%
↓ -1197.6% 61th
FCF / Share Free cash flow per share
$0.28
↓ -4.7%
Long-Term Debt Long-term obligations
$195.82M
— +0.1%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
53
Financial Health
60
Cash Quality
7

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 7 years · 27 quarters